Additionally, GP significantly decreased CD133 with a mild effect on LGR5 (the downregulation of CD133 and LGR5 is linked with growth inhibition of colon cancer cells) in normal colonic mucosa [515]. Here, LGR5 is linked to malignant colon neoplasm.